UBS analyst Kevin Caliendo raised the firm’s price target on McKesson (MCK) to $920 from $860 and keeps a Buy rating on the shares.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK:
- Trump Trade: Trump administration prepares new probe into pharma prices
- Trump admin prepares new probe into U.S. pharma prices, FT says
- Citius Oncology announces distribution agreement with McKesson
- McKesson’s Strategic Initiatives and Growth Potential Justify Buy Rating and Increased Price Target
- McKesson price target raised to $900 from $820 at Jefferies